Current Report Filing (8-k)
December 17 2014 - 4:18PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): December 17, 2014
|
|
Zoetis Inc. |
(Exact name of registrant as specified in its charter) |
|
| | | | |
Delaware | | 001-35797 | | 46-0696167 |
(State or other jurisdiction | | (Commission File | | (I.R.S. Employer |
of incorporation) | | Number) | | Identification No.) |
|
| | |
100 Campus Drive, Florham Park, NJ | | 07932 |
(Address of principal executive offices) | | (Zip Code) |
|
|
(973) 822-7000 |
(Registrant's telephone number, including area code) |
|
|
Not Applicable |
(Former Name or Former Address, if changed since last report) |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2 (b))
| |
o | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 7.01. Regulation FD Disclosure.
On December 17, 2014, the Board of Directors of Zoetis Inc. (the Company) declared a dividend of $0.083 per share for the first quarter of 2015. The dividend will be paid on March 3, 2015, to all holders of record of the Company's common stock as of the close of business on January 22, 2015.
Item 9.01. Financial Statements and Exhibits.
99.1 Press Release issued on December 17, 2014.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
| | |
ZOETIS INC. |
| |
By: | | /s/ Heidi C. Chen |
Name: | | Heidi C. Chen |
Title: | | Executive Vice President, |
| | General Counsel and Corporate Secretary |
Dated: December 17, 2014
INDEX OF EXHIBITS
|
| | |
|
Exhibit | | |
Number | | Description |
| | |
99.1 | | Press Release issued on December 17, 2014. |
Exhibit 99.1
For immediate release:
December 17, 2014
|
| | |
Media Contacts: | | Investor Contacts: |
Bill Price | | John O'Connor |
1-973-443-2742 (o) | | 1-973-822-7088 (o) |
william.price@zoetis.com | | |
| | |
Kristen Seely | |
|
1-973-443-2777 (o) | |
|
kristen.seely@zoetis.com | | |
Zoetis Declares First Quarter 2015 Dividend; Board Approves 15% Payment Increase
FLORHAM PARK, N.J. - December 17, 2014 - The Board of Directors of Zoetis Inc. (NYSE:ZTS) has declared a first quarter 2015 dividend payable to holders of the company’s common stock of $0.083 per share, an increase of 15% from the quarterly dividend rate paid in 2014. The dividend is to be paid on Tuesday, Mar. 3, 2015, to holders of record on Thursday, Jan. 22, 2015.
"In 2014, we continued to demonstrate the strength of our business model and deliver our long-term value proposition, including returning capital to our shareholders through our quarterly dividends and recently announced share repurchase program," said Zoetis Chief Financial Officer Juan Ramón Alaix. "With the Board's approval, I am pleased to announce we are increasing our dividend by 15% as we head into 2015 and continuing our commitment to effective and efficient use of our cash."
About Zoetis
Zoetis (zô-EH-tis) is the leading animal health company, dedicated to supporting its customers and their businesses. Building on more than 60 years of experience in animal health, Zoetis discovers, develops, manufactures and markets veterinary vaccines and medicines, complemented by diagnostic products and genetic tests and supported by a range of services. In 2013, the company generated annual revenue of $4.6 billion. With approximately 9,800 employees worldwide at the beginning of 2014, Zoetis has a local presence in approximately 70 countries, including 28 manufacturing facilities in 11 countries. Its products
serve veterinarians, livestock producers and people who raise and care for farm and companion animals in 120 countries. For more information, visit www.zoetis.com.
DISCLOSURE NOTICES
Forward-Looking Statements: This press release may contain forward-looking statements, which reflect Zoetis's current views with respect to business plans or prospects, future operating or financial performance, expectations regarding indebtedness, future use of cash and dividend payments, and other future events. These statements are not guarantees of future performance or actions. Forward-looking statements are subject to risks and uncertainties. If one or more of these risks or uncertainties materialize, or if management's underlying assumptions prove to be incorrect, actual results may differ materially from those contemplated by a forward-looking statement. Forward-looking statements speak only as of the date on which they are made. Zoetis expressly disclaims any obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise. A further list and description of risks, uncertainties and other matters can be found in our Annual Report on Form 10-K for the fiscal year ended December 31, 2013, including in the sections thereof captioned “Forward-Looking Information and Factors That May Affect Future Results” and “Item 1A. Risk Factors,” in our Quarterly Reports on Form 10-Q and in our Current Reports on Form 8-K. These filings and subsequent filings are available online at www.sec.gov, www.zoetis.com, or on request from Zoetis.
# # #
Zoetis (NYSE:ZTS)
Historical Stock Chart
From Jun 2024 to Jul 2024
Zoetis (NYSE:ZTS)
Historical Stock Chart
From Jul 2023 to Jul 2024
